{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T14:18:46Z","timestamp":1794320326440,"version":"4.9.0"},"reference-count":48,"publisher":"Bentham Science Publishers Ltd.","issue":"3","content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["CDM"],"published-print":{"date-parts":[[2026,5]]},"abstract":"<jats:sec>\n                    <jats:title>Introduction:<\/jats:title>\n                    <jats:p>Type 2 diabetes management remains challenging because of low bioavailability, side effects, and poor compliance with oral therapies. Transdermal delivery methods offer a non-invasive therapeutic approach with sustained delivery, which avoids first-pass metabolism.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>A total of 207 different phytochemicals were virtually screened using i-dock against the diabetic target, PPAR-\u03b3. Subsequently, three matrix-type transdermal patches were developed: a patch containing pure baicalin, a standard patch containing metformin, and a baicalin-loaded phytosomal patch. Phytosomes loaded with baicalin were optimized by using Central Composite Design and evaluated for their physicochemical properties, drug content, physical strength, in vitro, and ex vivo studies. In vivo antidiabetic efficacy was also studied in diabetic Wistar rats over 21 days, followed by a comparison of all formulations, including histopathological analysis of pancreatic tissue.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>Molecular docking studies showed promising results; baicalin has a high binding affinity for PPAR-\u03b3 (-9.8 kcal\/mol). The optimized phytosomal patch confirmed a uniform drug content (91.4 \u00b1 0.12 %) and showed sustained release over 12 hours. The ex vivo permeation study showed a significantly higher skin flux for the phytosomal patch (83.6%). In vivo studies confirmed that baicalin-loaded phytosomal patches showed significant blood glucose reductions (223 \u00b1 0.32 to 96 \u00b1 0.38 levels by Day 21), a comparable efficacy to standard metformin patches (224 \u00b1 0.37mg\/dL to 94 \u00b1 0.34 mg\/dL by Day 21).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Discussion:<\/jats:title>\n                    <jats:p>The enhanced skin permeation, penetration, and sustained-release exhibited by the phytosomal transdermal patch can be explained by the phospholipid-based shell structure, leading to better affinity with the skin, facilitating retention of the drug. The comparable glycemic control observed with metformin indicates that baicalin-loaded phytosomal transder-mal patches can achieve effective therapeutic concentrations via transdermal delivery, which is corroborated across two studies. These observations are consistent with previous literature documenting improved solubility and bioavailability of plant-derived actives utilizing phyto-some-based systems, which have applicability for chronic metabolic diseases such as T2DM.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>The developed phytosomal transdermal patch showed sustained release, better permeation, and potent antidiabetic activity; thus, it offers an alternative to conventional T2DM therapies.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.2174\/0113892002437368260113092840","type":"journal-article","created":{"date-parts":[[2026,3,25]],"date-time":"2026-03-25T11:55:10Z","timestamp":1774439710000},"page":"198-214","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Development and Evaluation of a Baicalin-loaded Phytosomal Transdermal Patch for Type 2 Diabetes Mellitus"],"prefix":"10.2174","volume":"27","author":[{"ORCID":"https:\/\/orcid.org\/0009-0007-4522-9211","authenticated-orcid":true,"given":"Priya","family":"Singhal","sequence":"first","affiliation":[{"name":"Noida Institute of Engineering and Technology (Pharmacy Institute), Greater Noida-201306, Uttar Pradesh, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1888-548X","authenticated-orcid":true,"given":"Rupa","family":"Mazumder","sequence":"additional","affiliation":[{"name":"Noida Institute of Engineering and Technology (Pharmacy Institute), Greater Noida-201306, Uttar Pradesh, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7575-7580","authenticated-orcid":true,"given":"Anjna","family":"Rani","sequence":"additional","affiliation":[{"name":"Noida Institute of Engineering and Technology (Pharmacy Institute), Greater Noida-201306, Uttar Pradesh, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1056-1197","authenticated-orcid":true,"given":"Abhijit","family":"Debnath","sequence":"additional","affiliation":[{"name":"Noida Institute of Engineering and Technology (Pharmacy Institute), Greater Noida-201306, Uttar Pradesh, India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"publisher","first-page":"S11","DOI":"10.2337\/dc17-S005","volume":"40","year":"2017","unstructured":"American Diabetes Association 2. Classification and Diagnosis of Diabetes. Diabetes Care  2017,40(Suppl. 1),S11-S24","journal-title":"Diabetes Care"},{"key":"ref=2","doi-asserted-by":"publisher","first-page":"e130423215752","DOI":"10.2174\/1573399819666230413094200","volume":"20","author":"Kumar A.","year":"2024","unstructured":"Kumar A.; Gangwar R.; Ahmad Zargar A.; Kumar R.; Sharma A.; Prevalence of diabetes in India: A review of IDF Diabetes Atlas 10th edition. Curr Diabetes Rev  2024,20(1),e130423215752","journal-title":"Curr Diabetes Rev"},{"key":"ref=3","doi-asserted-by":"publisher","first-page":"6984","DOI":"10.3390\/jcm12226984","volume":"12","author":"Swamy S.","year":"2023","unstructured":"Swamy S.; Noor S.M.; Mathew R.O.; Cardiovascular disease in diabetes and chronic kidney disease. J Clin Med  2023,12(22),6984","journal-title":"J Clin Med"},{"key":"ref=4","doi-asserted-by":"publisher","DOI":"10.1007\/s10389-025-02448-7","author":"Almalki W.H.","year":"2025","unstructured":"Almalki W.H.; Khan M.S.; Burden of diabetes mellitus on health and economy of the Arab world: Current situation and perspectives. J Public Health  2025","journal-title":"J Public Health"},{"key":"ref=5","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1186\/s12933-025-02665-0","volume":"24","author":"Lian H.","year":"2025","unstructured":"Lian H.; Ren Q.; Liu W.; Zhang R.; Zou X.; Zhang S.; Luo Y.; Deng W.; Wang Q.; Qi L.; Li Y.; Wang W.; Zhong L.; Zhang P.; Guo C.; Li L.; Li Y.; Ba T.; Yang C.; Huo L.; Wang Y.; Li C.; Hao D.; Zhang Y.; Xu Y.; Wang F.; Wang X.; Zhang F.; Gong S.; Yang W.; Han X.; Ji L.; Cardiovascular abnormalities already occurred in newly-diagnosed patients with early-onset type 2 diabetes. Cardiovasc Diabetol  2025,24(1),140","journal-title":"Cardiovasc Diabetol"},{"key":"ref=6","doi-asserted-by":"publisher","first-page":"100085","DOI":"10.1016\/j.nwnano.2025.100085","volume":"9","author":"Patil K.","year":"2025","unstructured":"Patil K.; Salve P.S.; Hussain U.M.H.; Tatode A.; Qutub M.; Enhanced therapy for diabetic neuropathy utilizing venlafaxine hydrochloride-loaded transferosome-based transdermal gel. Nano Trends  2025,9,100085","journal-title":"Nano Trends"},{"key":"ref=7","doi-asserted-by":"publisher","first-page":"e250324228308","DOI":"10.2174\/0122103155281428240320091344","volume":"15","author":"Ahmed A.","year":"2025","unstructured":"Ahmed A.; Ahmad R.; Jangir S.; Sharma D.; Current development and application on inclusion of herbal phytochemicals in novel herbal drug delivery system. Nat Prod J  2025,15(1),e250324228308","journal-title":"Nat Prod J"},{"key":"ref=8","doi-asserted-by":"publisher","first-page":"1475","DOI":"10.3390\/pharmaceutics13091475","volume":"13","author":"Alharbi W.S.","year":"2021","unstructured":"Alharbi W.S.; Almughem F.A.; Almehmady A.M.; Jarallah S.J.; Alsharif W.K.; Alzahrani N.M.; Alshehri A.A.; Phytosomes as an emerging nanotechnology platform for the topical delivery of bioactive phytochemicals. Pharmaceutics  2021,13(9),1475","journal-title":"Pharmaceutics"},{"key":"ref=9","doi-asserted-by":"publisher","first-page":"1020","DOI":"10.2174\/1570180819666220615092854","volume":"20","author":"Mahmoudabad A.G.","year":"2023","unstructured":"Mahmoudabad A.G.; Shirshahi V.; Mehrabi M.; Gheybi F.; Gharravi A.M.; Salehi M.; Masoudi A.; Phytosome: An effective transdermal drug delivery system for phytoconstituents. Lett Drug Des Discov  2023,20(8),1020-1030","journal-title":"Lett Drug Des Discov"},{"key":"ref=10","doi-asserted-by":"publisher","first-page":"115238","DOI":"10.1016\/j.jep.2022.115238","volume":"293","author":"Yan X.","year":"2022","unstructured":"Yan X.; Zhang Y.; Peng Y.; Li X.; The water extract of Radix scutellariae, its total flavonoids and baicalin inhibited CYP7A1 expression, improved bile acid, and glycolipid metabolism in T2DM mice. J Ethnopharmacol  2022,293,115238","journal-title":"J Ethnopharmacol"},{"key":"ref=11","doi-asserted-by":"publisher","first-page":"153869","DOI":"10.1016\/j.phymed.2021.153869","volume":"95","author":"Yu M.","year":"2022","unstructured":"Yu M.; Han S.; Wang M.; Han L.; Huang Y.; Bo P.; Fang P.; Zhang Z.; Baicalin protects against insulin resistance and metabolic dysfunction through activation of GALR2\/GLUT4 signaling. Phytomedicine  2022,95,153869","journal-title":"Phytomedicine"},{"key":"ref=12","doi-asserted-by":"publisher","first-page":"431","DOI":"10.3390\/ijms25010431","volume":"25","author":"Szkudelski T.","year":"2023","unstructured":"Szkudelski T.; Szkudelska K.; The anti-diabetic potential of baicalin: Evidence from rodent studies. Int J Mol Sci  2023,25(1),431","journal-title":"Int J Mol Sci"},{"key":"ref=13","first-page":"214","volume":"31","author":"Lu W.","year":"2012","unstructured":"Lu W.; Meng X.; Jia G.; Zhao C.; Zhang L.; Ren Y.; Ni Y.; Pan H.; Meng X.; Jia G.; Baicalin normalizes blood glucose level in streptozotocin -induced diabetic rats. Lat Am J Pharm  2012,31,214-219","journal-title":"Lat Am J Pharm"},{"key":"ref=14","doi-asserted-by":"publisher","first-page":"3581","DOI":"10.1080\/14786419.2024.2334323","volume":"39","author":"Shafi S.","year":"2025","unstructured":"Shafi S.; Khurana N.; Gupta J.; PPAR gamma agonistic activity of dillapiole: Protective effects against diabetic nephropathy. Nat Prod Res  2025,39(12),3581-3586","journal-title":"Nat Prod Res"},{"key":"ref=15","doi-asserted-by":"publisher","first-page":"118355","DOI":"10.1016\/j.jep.2024.118355","volume":"332","author":"Zhu Z.","year":"2024","unstructured":"Zhu Z.; Yu M.; Xu M.; Ji X.; Zong X.; Zhang Z.; Shang W.; Zhang L.; Fang P.; Baicalin suppresses macrophage JNK-mediated adipose tissue inflammation to mitigate insulin resistance in obesity. J Ethnopharmacol  2024,332,118355","journal-title":"J Ethnopharmacol"},{"key":"ref=16","doi-asserted-by":"publisher","first-page":"3654","DOI":"10.3390\/ijms25073654","volume":"25","author":"Zhao W.","year":"2024","unstructured":"Zhao W.; Cui H.; Liu K.; Yang X.; Xing S.; Li W.; Unveiling anti-diabetic potential of baicalin and baicalein from baikal skullcap: LC\u2013MS, in silico, and in vitro studies. Int J Mol Sci  2024,25(7),3654","journal-title":"Int J Mol Sci"},{"key":"ref=17","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/j.ejmech.2017.09.049","volume":"141","author":"Wang T.","year":"2017","unstructured":"Wang T.; Jiang H.; Cao S.; Chen Q.; Cui M.; Wang Z.; Li D.; Zhou J.; Wang T.; Qiu F.; Kang N.; Baicalin and its metabolites suppresses gluconeogenesis through activation of AMPK or AKT in insulin resistant HepG-2 cells. Eur J Med Chem  2017,141,92-100","journal-title":"Eur J Med Chem"},{"key":"ref=18","doi-asserted-by":"publisher","first-page":"21435","DOI":"10.1038\/s41598-025-06862-5","volume":"15","author":"Pham N.T.","year":"2025","unstructured":"Pham N.T.; Le H.G.; Phan T.T.T.; Luu P.V.; Peng B.R.; Chen L.Y.; Chang Y.C.; Lai K.H.; Dual therapeutic potential of Scoparia dulcis in combating hyperglycemia and inflammation in diabetes through network pharmacology and in silico analysis. Sci Rep  2025,15(1),21435","journal-title":"Sci Rep"},{"key":"ref=19","doi-asserted-by":"publisher","first-page":"10167","DOI":"10.1080\/07391102.2025.2498622","volume":"43","author":"Kumar A.","year":"2025","unstructured":"Kumar A.; Purohit N.; Singh P.P.; Jangid K.; Kumar V.; Bharat J.S.; Chakraborty S.; Kumar V.; Jaitak V.; Identification of phytochemicals from genus Potentilla as estrogen receptor-\u03b1 inhibitors through molecular docking, molecular dynamic simulation and DFT calculations. J Biomol Struct Dyn  2025,43(17),10167-10183","journal-title":"J Biomol Struct Dyn"},{"key":"ref=20","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1007\/s40203-025-00304-w","volume":"13","author":"Ottu P.O.","year":"2025","unstructured":"Ottu P.O.; Babalola O.O.; Oluwamodupe C.; Oluwatobiloba A.F.; Kehinde I.O.; Akinola O.A.; Ibrahim S.O.; Elekofehinti O.O.; Investigation of Aframomum melegueta compounds as ERK5 inhibitor related to breast cancer via molecular docking and dynamic simulation. In Silico Pharmacol  2025,13(1),18","journal-title":"In Silico Pharmacol"},{"key":"ref=21","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1007\/s40203-025-00349-x","volume":"13","author":"Janakiramulu P.","year":"2025","unstructured":"Janakiramulu P.; Mamidala E.; Molecular docking and dynamic simulation analysis of flavonoid derivatives as COX-2 inhibitors. In Silico Pharmacol  2025,13(2),59","journal-title":"In Silico Pharmacol"},{"key":"ref=22","doi-asserted-by":"publisher","first-page":"790","DOI":"10.3390\/molecules30040790","volume":"30","author":"Cai H.","year":"2025","unstructured":"Cai H.; Liao S.; Li J.; Lv M.; Lin X.; Song Y.; Chen X.; Zhu Y.; Zhang J.; Qi N.; Sun M.; Structure-based virtual screening of potential inhibitors targeting the Prolyl-tRNA Synthetase (PRS) in Eimeria tenella: Insights from molecular docking, ADMET studies, and molecular dynamics simulations. Molecules  2025,30(4),790","journal-title":"Molecules"},{"key":"ref=23","doi-asserted-by":"publisher","first-page":"5834","DOI":"10.3390\/ijms24065834","volume":"24","author":"Paczkowska-Walendowska M.","year":"2023","unstructured":"Paczkowska-Walendowska M.; Miklaszewski A.; Szymanowska D.; Skalicka-Wo\u017aniak K.; Cielecka-Piontek J.; Hot melt extrusion as an effective process in the development of mucoadhesive tablets containing Scutellariae baicalensis radix extract and chitosan dedicated to the treatment of oral infections. Int J Mol Sci  2023,24(6),5834","journal-title":"Int J Mol Sci"},{"key":"ref=24","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1016\/j.matpr.2016.02.019","volume":"3","author":"Maryana W.","year":"2016","unstructured":"Maryana W.; Rachmawati H.; Mudhakir D.; Formation of phytosome containing silymarin using thin layer-hydration technique aimed for oral delivery. Mater Today Proc  2016,3(3),855-866","journal-title":"Mater Today Proc"},{"key":"ref=25","doi-asserted-by":"publisher","first-page":"194","DOI":"10.3390\/jfb16060194","volume":"16","author":"Olfati A.","year":"2025","unstructured":"Olfati A.; Karimi N.; Arkan E.; Zhaleh M.; Mozafari M.R.; Enhancing bioavailability and stability of plant secondary metabolites: Formulation and characterization of nanophytosomes encapsulating red bryony and horned poppy extracts. J Funct Biomater  2025,16(6),194","journal-title":"J Funct Biomater"},{"key":"ref=26","doi-asserted-by":"publisher","first-page":"142","DOI":"10.22270\/jddt.v15i3.7044","volume":"15","author":"Biswas Majee S.","year":"2025","unstructured":"Biswas Majee S.; Gupti S.; Mishra T.; Bera R.; In vitro, ex vivo and in vivo studies on anti-hypertensive-loaded transdermal and buccal patches. J Drug Deliv Ther  2025,15(3),142-150","journal-title":"J Drug Deliv Ther"},{"key":"ref=27","doi-asserted-by":"publisher","first-page":"9411","DOI":"10.2147\/IJN.S467811","volume":"19","author":"Dewi M.","year":"2024","unstructured":"Dewi M.; Muhaimin M.; Joni I.; Hermanto F.; Chaerunisaa A.; Fabrication of phytosome with enhanced activity of Sonneratia alba: Formulation modeling and in vivo antimalarial study. Int J Nanomedicine  2024,19,9411-9435","journal-title":"Int J Nanomedicine"},{"key":"ref=28","doi-asserted-by":"publisher","first-page":"8019","DOI":"10.37275\/bsm.v9i7.1333","volume":"9","author":"Siti Mardiyanti","year":"2025","unstructured":"Siti Mardiyanti; Effionora Anwar; Yesi Desmiaty; Siti Sadiyah; Novel Enhalus acoroides Phytosomes: Formulation, Characterization, and Bioavailability Enhancement. Biosci Med  2025,9(7),8019-8032","journal-title":"Biosci Med"},{"key":"ref=29","doi-asserted-by":"publisher","first-page":"s326","DOI":"10.5530\/ijper.56.2s.103","volume":"56","author":"Rani A.","year":"2022","unstructured":"Rani A.; Kumar S.; Khar R.K.; Murraya koenigii extract loaded phytosomes prepared using antisolvent precipitation technique for improved antidiabetic and hypolidemic activity. Indian J Pharm Educ Res  2022,56(2s),s326-s338","journal-title":"Indian J Pharm Educ Res"},{"key":"ref=30","doi-asserted-by":"publisher","first-page":"6678786","DOI":"10.1155\/sci5\/6678786","volume":"2025","author":"Asar T.O.","year":"2025","unstructured":"Asar T.O.; Milibary G.A.; Almehmady A.M.Y.; Y Rizg W.; I Felimban R.; H Alnadwi F.; Omar A.M.; El-Say K.M.; Ahmed T.A.; Next-generation oral delivery systems: Phytosomal hinokitiol tablets via REGEMAT 3D bioprinter-based 3D printing for enhanced bioavailability. Scientifica  2025,2025,6678786","journal-title":"Scientifica"},{"key":"ref=31","doi-asserted-by":"publisher","first-page":"10","DOI":"10.12928\/clips.v1i2.366","volume":"1","author":"Maesaroh I.","year":"2025","unstructured":"Maesaroh I.; Anjani S.; Formulation and evaluation of transdermal patch preparations from ethanol extract of green tea leaves (Camellia sinensis (L.) Kuntze). Clin Pharm Sci J  2025,1(2),10-17","journal-title":"Clin Pharm Sci J"},{"key":"ref=32","doi-asserted-by":"publisher","DOI":"10.1089\/adt.2025.010","author":"Siddheshwar S.S.","year":"2025","unstructured":"Siddheshwar S.S.; Jadhav S.; Mankar S.D.; Ghorpade A.C.; Development and fabrication of emodin-loaded patches using geraniol as a penetration enhancer for transdermal delivery. Assay Drug Dev Technol  2025","journal-title":"Assay Drug Dev Technol"},{"key":"ref=33","doi-asserted-by":"publisher","first-page":"936","DOI":"10.5530\/ijper.20250924","volume":"59","author":"Kumar A.","year":"2025","unstructured":"Kumar A.; Maurya P.; Narayan K.P.; Fabrication of polymeric matrix type transdermal patch containing glimepiride for therapeutic management of type-2 diabetes. Indian J Pharm Educ Res  2025,59(3),936-948","journal-title":"Indian J Pharm Educ Res"},{"key":"ref=34","doi-asserted-by":"publisher","first-page":"100363","DOI":"10.1016\/j.ijpx.2025.100363","volume":"10","author":"Liu Y.","year":"2025","unstructured":"Liu Y.; Chen G.; Li M.; Li M.; Xie D.; Luo Z.; Development of long-acting riluzole transdermal patch against amyotrophic lateral sclerosis: Mechanistic insights into polyglyceryl-3 dioleate-enhanced drug release and skin permeation. Int J Pharm X  2025,10,100363","journal-title":"Int J Pharm X"},{"key":"ref=35","doi-asserted-by":"publisher","first-page":"100151","DOI":"10.1016\/j.nxnano.2025.100151","volume":"8","author":"Satpute R.","year":"2025","unstructured":"Satpute R.; Salve P.S.; Qutub M.; Hussain U.M.H.; Gadge J.; Enhanced systemic delivery of mirtazapine through transdermal drug-in-adhesive matrix: A sustained-release approach. Next Nanotechnol  2025,8,100151","journal-title":"Next Nanotechnol"},{"key":"ref=36","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/j.jhip.2025.06.002","volume":"6","author":"P\u0131nar Ya\u011fc\u0131lar A.","year":"2025","unstructured":"P\u0131nar Ya\u011fc\u0131lar A.; G\u00fcven G.K.; \u015eefik \u00c7a\u011flar E.; Okur N.\u00dc.; Siafaka P.I.; Development and ex vivo \/ in vitro evaluation of sodium alginate\/ hydroxypropyl methylcellulose films for dermal and\/or transdermal delivery of p-hydroxycinnamic acid. J Holistic Integr Pharm  2025,6(2),175-183","journal-title":"J Holistic Integr Pharm"},{"key":"ref=37","doi-asserted-by":"publisher","first-page":"52","DOI":"10.22270\/jddt.v15i1.6951","volume":"15","author":"Kumar M.","year":"2025","unstructured":"Kumar M.; Bose P.; Singh A.P.; Singh A.P.; Formulation and evaluation of betulinic acid loaded transdermal patches. J Drug Deliv Ther  2025,15(1),52-58","journal-title":"J Drug Deliv Ther"},{"key":"ref=38","doi-asserted-by":"publisher","first-page":"1204","DOI":"10.1038\/s41598-024-81918-6","volume":"15","author":"Qadir A.","year":"2025","unstructured":"Qadir A.; Jan S.U.; Shoaib M.H.; Sikandar M.; Yousuf R.I.; Ali F.R.; Siddiqui F.; Magsi A.J.; Mustafa G.; Saleem M.T.; Mohammad S.; Younis M.; Arsalan M.; Formulation development and evaluation, in silico PBPK modeling and in vivo pharmacodynamic studies of clozapine matrix type transdermal patches. Sci Rep  2025,15(1),1204","journal-title":"Sci Rep"},{"key":"ref=39","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1186\/s13065-025-01446-w","volume":"19","author":"Jayadev S.","year":"2025","unstructured":"Jayadev S.; Yusuff I.; Shakeel F.; Uthumansha U.; Ultra-performance liquid chromatography method for quantitative analysis of nystatin and triamcinolone acetonide in topical creams after in vitro release using franz diffusion cell. BMC Chem  2025,19(1),74","journal-title":"BMC Chem"},{"key":"ref=40","doi-asserted-by":"publisher","DOI":"10.2174\/0113816128335012250122221541","volume":"31","author":"Chakraborty R.","year":"2025","unstructured":"Chakraborty R.; Gohain R.B.; Talukdar P.; Changkakoti L.; Biswas S.; Mukherjee A.K.; Bala A.; Pre-clinical safety study of Cold Atmospheric Plasma (CAP) produced by an inbuilt cap device and ROS mediated apoptotic activity in human skin melanoma cells. CPD  2025,31","journal-title":"CPD"},{"key":"ref=41","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.toxlet.2025.04.011","volume":"409","author":"Hansen T.","year":"2025","unstructured":"Hansen T.; Tillmann T.; Wiench K.; Creutzenberg O.; Studies on acute dermal toxicity and dermal absorption of a nanoform zinc oxide (ZnO; NM-111) in rats. Toxicol Lett  2025,409,42-49","journal-title":"Toxicol Lett"},{"key":"ref=42","doi-asserted-by":"publisher","first-page":"1006","DOI":"10.3390\/life15071006","volume":"15","author":"Petrovi\u0107 M.","year":"2025","unstructured":"Petrovi\u0107 M.; Trenki\u0107 M.; Veselinovi\u0107 M.; Smiljkovi\u0107 A.; Sokolovi\u0107 D.; Biochemical study of bilberry extract potential in preventing retinal damage in rat model of diabetes induced by streptozotocin\/nicotinamide. Life  2025,15(7),1006","journal-title":"Life"},{"key":"ref=43","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1186\/s12906-025-04933-8","volume":"25","author":"Razali N.I.","year":"2025","unstructured":"Razali N.I.; Widyawati T.; Anggraini D.R.; Lim V.; Yusoff N.A.; Effect of nipa palm (Nypa fruticans Wurmb.) vinegar on the incretin hormones and intestinal glucose transporters in type 2 diabetes mellitus rat model. BMC Complement Med Ther  2025,25(1),192","journal-title":"BMC Complement Med Ther"},{"key":"ref=44","doi-asserted-by":"publisher","first-page":"4712","DOI":"10.3390\/ijms26104712","volume":"26","author":"Usatiuc L.O.","year":"2025","unstructured":"Usatiuc L.O.; Pop R.M.; Adrian S.; P\u00e2rvu M.; \u021aicolea M.; Uif\u0103lean A.; V\u0103lean D.; Gavrila\u0219 L.I.; Csilla-Enik\u0151 S.; Leopold L.F.; Ranga F.; C\u0103toi F.A.; P\u00e2rvu A.E.; Multitargeted effects of Plantago ovata ethanol extract in experimental rat streptozotocin-induced diabetes mellitus and letrozole-induced polycystic ovary syndrome. Int J Mol Sci  2025,26(10),4712","journal-title":"Int J Mol Sci"},{"key":"ref=45","doi-asserted-by":"publisher","first-page":"583","DOI":"10.3390\/pharmaceutics17050583","volume":"17","author":"Almuqbil R.M.","year":"2025","unstructured":"Almuqbil R.M.; Aldhubiab B.; Ethosome-based transdermal drug delivery: Its structural components, preparation techniques, and therapeutic applications across metabolic, chronic, and oncological conditions. Pharmaceutics  2025,17(5),583","journal-title":"Pharmaceutics"},{"key":"ref=46","doi-asserted-by":"publisher","first-page":"138496","DOI":"10.1016\/j.ijbiomac.2024.138496","volume":"287","author":"Karthick V.","year":"2025","unstructured":"Karthick V.; Zahir A.A.; Amalraj S.; Rahuman A.A.; Anbarasan K.; Santhoshkumar T.; Sustained release of nano-encapsulated glimepiride drug with chitosan nanoparticles: A novel approach to control type 2 diabetes in streptozotocin-induced Wistar albino rats. Int J Biol Macromol  2025,287,138496","journal-title":"Int J Biol Macromol"},{"key":"ref=47","doi-asserted-by":"publisher","first-page":"2508908","DOI":"10.1080\/0886022X.2025.2508908","volume":"47","author":"Bao N.","year":"2025","unstructured":"Bao N.; Gu M.J.; Huang Q.Y.; Sun H.J.; Zhu X.X.; Gu X.; Wang J.; Yu X.; Lu Q.B.; Yu Y.F.; Baicalin alleviates sepsis-associated acute kidney injury through activation of the PPAR-\u03b3\/UCP1 signaling pathway. Ren Fail  2025,47(1),2508908","journal-title":"Ren Fail"},{"key":"ref=48","doi-asserted-by":"publisher","first-page":"1551256","DOI":"10.3389\/fimmu.2025.1551256","volume":"16","author":"Cai Y.","year":"2025","unstructured":"Cai Y.; Yang Q.; Tang X.; Wang P.; Cui J.; Du X.; Zhang T.; Chen Y.; Baicalin mitigates hyperglycemia-linked intestinal epithelial barrier impairment in part by inhibiting the formation of neutrophil extracellular traps. Front Immunol  2025,16,1551256","journal-title":"Front Immunol"}],"container-title":["Current Drug Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/0113892002437368260113092840","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/251324\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/0113892002437368260113092840","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T04:20:56Z","timestamp":1790914856000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/251324\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":48,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,5]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/0113892002437368260113092840","relation":{},"ISSN":["1389-2002"],"issn-type":[{"value":"1389-2002","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Double blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2025-08-13","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-11-20","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-11-29","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-09-02","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}